Author:
Aptsiauri Natalia,Garcia-Lora Angel Miguel,Cabrera Teresa
Reference77 articles.
1. Ahmad M, Rees RC, Ali SA (2004) Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother 53:844–854
2. Amerik AY, Hochstrasser M (2004) Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695(1–3):189–207
3. Aoe T, Okamoto Y, Saito T (1995) Activated macrophages induce structural abnormalities of the T-cell receptor-CD3 complex. J Exp Med 181(5):1881–1886
4. Aptsiauri N, Cabrera T, Garcia-Lora A, Lopez-Nevot MA, Ruiz-Cabello F, Garrido F (2007) MHC class I antigens and immune surveillance in transformed cells. Int Rev Cytol 256:139–189
5. Aruga A, Aruga E, Tanigawa K, Bishop DK, Sondak VK, Chang AE (1997) Type 1 versus type 2 cytokine release by V beta T cell subpopulations determines in vivo anti-tumor reactivity—IL-10 mediates a suppressive role. J Immunol 159(2):664–673